|
Report Date : |
29.06.2012 |
IDENTIFICATION DETAILS
|
Name : |
GROUPE CHINGUITTY PHARMA |
|
|
|
|
Registered Office : |
45 Lot 3, Immeuble Chinguitty, Tavragh Zeina, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2008 |
|
|
|
|
Date of Incorporation : |
01.09.1992 |
|
|
|
|
Com. Reg. No.: |
16270 |
|
|
|
|
Legal Form : |
Societe Anonyme |
|
|
|
|
Line of Business : |
Wholesaler
of pharmaceutical goods |
|
|
|
|
No. of Employees : |
96 |
RATING & COMMENTS
|
MIRA’s Rating : |
A |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
|
C1 |
C1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
GROUPE CHINGUITTY PHARMA
Payment Record: NO COMPLAINTS
This rating
is based on available data. In the event of additional information a
possibility for a different rating applies.
Registration Number: 16270
Registration Date: 01/09/1992
Legal Form: SOCIETE ANONYME
Latest Financials: December 31, 2008
Nominal Capital: 20,000,000 Mauritanian Ouguiya
Issued Capital: N/A
Turnover: 7,789,025,401 Mauritanian Ouguiya
Net Profit: 370,911,068 Mauritanian Ouguiya
Net Worth: 2,185,315,292 Mauritanian Ouguiya
Company
Name: GROUPE
CHINGUITTY PHARMA
Also
trades as: GC.
PHARMA
Headquarter
Address: 45
Lot 3, Immeuble Chinguitty,
Tavragh Zeina,
Nouakchott,
Mauritania
Postal
Address: P.O.Box
2309,
Nouakchott
Telephone: +2224524
2016
+2224525 7672
+2224525 9742
+2224645 6785
Fax: +2224525
6623
E‑Mail: gcpharma@gcpharma.mr
Web
Site: www.gcpharma.mr
Company
has been in it's present legal form since: 2010
Company
was originally started as a SOCIETE A RESPONSIBILITE LIMITEE on 01/09/1992
Current
Legal Form: SOCIETE
ANONYME
Registration
Address: 45
Lot 3, Immeuble Chinguitty,
Nouakchott
Registration
Number: 16270
Registration
Date: 01/09/1992
Year/Date
Company Established: 01/09/1992
Registration
Town: Nouakchott
Tax
Registration Number: 21400109
Currency: Mauritanian
Ouguiya
Authorized Capital: 20,000,000
Paid Up Capital: 20,000,000
Shareholders:
Name/Other Information Shares
Held % of
Voting/Non‑Voting
capital
Mr. Sidi Mohamed Ould Mohamed 50.00% (VOTING)
Lemine,
Mauritania
Mr. Mohamed Saleck Ould Sidi 25.00% (VOTING)
Mohamed,
Mauritania
Mr. Aly Ould Mohamed El Mehyi, 25.00% (VOTING)
Mauritania
Name: Mr
Sidi Mohamed Ould Mohamed Lemine
Position within the company: General Director
Country of Birth: Mauritania
Nationality: Mauritian
Can fluently speak: Arabic
& French
Name: Mr
Mohamed Ishak Ould Mohamed Lemine
Position within the company: Commercial Director
Additional Information: Mail : ishak@gcpharma.mr
Country of Birth: Mauritania
Nationality: Mauritanian
Can fluently speak: Arabic
& French
Name: Mr
Oghbeta Ould Dellahi
Position within the company: Financial & Administration Director
Country of Birth: Mauritania
Nationality: Mauritanian
Can fluently speak: Arabic
& French
NACE Codes: 4646 Wholesale
of pharmaceutical goods
The
company is engaged in import and distribution of pharmaceutical goods and
medical equipment.
Local
Reporters consider the investigated company to be LARGE in their field of
concern.
Employees Company Employs: 96
HQ Premises Operates from: Owned Offices , Shop, Warehouse
Location: Central
Business Area
Imports
Import % and type of product: 100% Finished Goods
Imports From: France,
Germany, Morocco, Tunisia,
United
Arab Emirates, India, Senegal
Importing Terms: Bank
transfer
Subject's Suppliers: Company
Name: BLEDINA
Address: France
Company Name: DENK
PHARMA
Address: Germany
Company Name: EPDIS
Address: France
Company Name: MEDIS
Address: Tunisia
Company Name: NESTLE
SENEGAL
Address: Senegal
Company Name: PIERRE
FABRE MEDICAMENT
Address: France
Company Name: PIEX
Address: France
Company Name: SANOFI
Address: France
Company Name: TRIDEM
Address: France
Exports
Export % and type of product: Subject does not export
Trading
& Selling
Territory: 100%
Nationally
Type of Customer: Pharmacists
& Hospitals
Number of accounts:
1,100
Vehicles: Total
number of vehicles: 17
9 trucks
6 vans
2 cars
Subsidiaries
Affiliates
CHINGUITTY VETERINAIRE
Nouakchott,
Mauritania
Operates as: Veterinary products
Related through: common principals and shareholders
CHINGUITTY COSMETIQUE
Nouakchott,
Mauritania
Operates as: Cosmetics
Related through: common principals and shareholders
BMCI :
Banque Mauritanienne pour le Commerce International,
Branch:
Head office
Avenue
Gamal Abdel Nasser, BP 622,
Nouakchott,
Mauritania
Account
Number: 01254410521
81
BNM :
Banque Nationale de Mauritanie,
Branch:
Head office
BP 291
et 614,
Nouakchott,
Mauritania
Account
Number: 3348/0
BCI :
Banque pour le Commerce et l'Industrie,
Branch:
Head office
Avenue
Gamal Abdel Nasser BP 5050,
Nouakchott,
Mauritania
Account
Number: 160420006
Al
Watani,
Branch:
Head office
Nouakchott,
Mauritania
Account
Number: 900011
Source: Mr.
Oghbeta Ould Dellahi Financial Director
Figures are: Official
Figures
Currency: Mauritanian
Ouguiya
Months Sales
Figures Sales Gross Profit/Loss Net
Profit/Loss
12 31/12/2011 7,789,025,401 370,911,068
12 31/12/2010 7,389,657,249 381,991,053
12 31/12/2009 6,842,275,231 434,456,941
12 31/12/2008 6,061,579,231 447,621,872
12 31/12/2007 4,457,763,727 222,459,500
12 31/12/2006 3,428,115,800 344,852,105
BALANCE
SHEET
As at: 31‑Dec‑2008 As at: 31‑Dec‑2007
As at: 31‑Dec‑2006
Fixed
Assets
Land & Buildings 423,321,500 325,913,661 194,275,230
Plant & Machinery 373,680 498,240 622,800
Furniture & Equipment 1,057,199 741,299 864,849
Motor Vehicles 2,784,000 6,496,000 10,208,000
Misc.
Fixed Assets
Total Fixed Assets 427,536,379 333,649,200 205,970,879
Financial
Assets
Shares
in Related Companies
Loans to
related companies
Investments
Deposits
Misc.
Financial Assets
Total Financial Assets 0 0 0
Intangibles
Goodwill
Organisational Expenses 92,000 92,000
Patents
Misc.
Intangible Assets
Total Intangible Assets 0 92,000 92,000
Current
Assets
Stock 1,217,566,329 829,850,204 407,810,019
Stock
& Work in Progress
Trade Debtors & receivables 428,512,478 399,520,397 264,202,154
Provision
for bad debs
Other receivables 6,007,230 4,585,000 8,350,000
Due from
related companies
Owed by shareholders
Prepaid expenses
Cash 351,642,259 208,987,630 154,267,440
Tax recoverable
Marketable
Securities
Misc. Current Assets
Total Current Assets 2,003,728,296 1,442,943,231 834,629,613
Total Assets 2,431,264,675 1,776,684,431 1,040,692,492
Owner's Equity
& Liabilities
Issued and paid up capital 10,000,000 10,000,000 10,000,000
Share premium
account
Retained earnings 1,727,693,420 1,505,233,920 284,981,279
Net profit/Loss for the year 447,621,872 222,459,500 344,852,105
Revaluation reserves
Legal Reserves
Other reserves
Net Worth 2,185,315,292 1,737,693,420 639,833,384
Deffered Taxation
Provisions/allowances
Mortgages/Loans
Hire purchase
Due to group of
companies
Minority interest
Misc. deferred
liabilities
Total Long Term Liabilities 0 0 0
Current
Liabilities
Creditors 245,019,823 36,451,200 352,390,193
Other
creditors 852,211 46,760,101
Accruals 401,760 1,687,600 1,708,814
Bank
overdrafts/Loans
Misc. Loans
Directors accounts
Owing to
shareholders
Owing to related
companies
Proposed dividend
Long Term‑due
1 year
Hire Purchase‑under
1 year
Taxation 527,800
Advance receipts
Misc. Current
Liabilities
Total Current Liabilities 245,949,383 38,991,011 400,859,108
Owner's Equity & Liabilities 2,431,264,675 1,776,684,431 1,040,692,492
PROFIT & LOSS
Figures are:
Figures are: Figures are:
Fiscal
Year Fiscal Year Fiscal
Year
01/01/2008 to 31/12/2008 01/01/2007
to 31/12/2007 01/01/2006 to
31/12/2006
Total Income/Turnover 6,061,597,231 4,457,763,727 3,428,115,800
Cost of sales
Gross Profit/(Loss) 6,061,597,231 4,457,763,727 3,428,115,800
Admin/selling expenses 5,087,707,151 3,991,451,200 2,842,125,529
Services 275,675,858 198,392,890 185,187,699
Salaries 3,205,000 38,774,290 34,219,544
Auditors Fee 45,658,960 78,129,361 69,114,524
Stock Depreciation 185,807,215 ‑84,680,970 ‑61,509,989
Depreciation 11,399,300 10,363,000 13,713,569
Misc. Operating Expenses 4,521,875 2,874,456 412,819
Misc. Operating Income
Net Operating Profit/(Loss) 447,621,872 222,459,500 344,852,105
Interest
Receivable/Finance Income
Group related income
Misc. Financial
Income
Total Financial Income 0 0 0
Interest
Payable/Finance costs
Misc. financial
expenses
Total Financial Expenses 0 0 0
Profit/(Loss) before taxes 447,621,872 222,459,500 344,852,105
Income Tax
Other Tax
Profit/(Loss) after taxes 447,621,872 222,459,500 344,852,105
Extraordinary items
Exceptional items
Misc. Items
Net Profit/(Loss) 447,621,872 222,459,500 344,852,105
Previous years
retained earnings
Current years net income 447,621,872 222,459,500 344,852,105
Misc. additions in
current year
Current years net
loss
Dividends in current
year
Withdrawals in
current year
Misc. deductions in current
year
Retained earnings at end of 447,621,872 222,459,500 344,852,105
financial period
Average employees
Directors fee
Earnings per share
Earnings per share‑previous
year
Date accounts obtained: 10/06/2009
Accounts obtained from: Subject
Auditors Opinion: The audited financial statement gives a
true and fair view of the state
of
affairs of the subject
Financial Statements have been prepared on an on‑going
basis.
Assuming support of: shareholders
Actual Company Industrial
Averages Actual Company Industrial Averages
Results (2008) (2008) Results (2007) (2007)
Liquidity Ratios
Current Ratio 8.15 6.15 37.01 15.22
Acid Test Ratio 3.20 2.76 15.72 6.25
Accounts 0.04 0.16 0.01 0.20
Payable/Sales Ratio
Current Liabilities/Net 0.11 0.46 0.02 0.33
Worth
Total Liabilities/Net 0.11 0.46 0.02 0.33
Worth
Fixed Assets/Net 19.56 17.47 19.20 16.25
Worth (%)
Profitability Ratios
Gross Profit Ratio (%) 100.00 48.07 100.00 52.98
Return on Capital 20.48 5.01 12.80 10.07
Employed (ROCE)(%)
Net Profit/Sales (%) 7.38 ‑0.22 4.99 5.46
Return on Assets (%) 18.41 6.77 12.52 8.27
Efficiency Ratios
Sales/Working Capital 3.45 2.40 3.18 2.30
Assets/Sales(%) 40.11 100.35 39.86 93.64
Shareholders 20.48 5.01 12.80 10.07
Return(%)
Average Collection 24.93 24.93 27.17 62.38
Period
Leverage Ratios
Capital Employed 2.77 2.06 2.57 1.91
Number
of 4 4
Companies within the
industry (NACE G)
Statistics
based on Wholesale
and retail Wholesale
and retail
NACE(G) trade;repair
of motor trade;repair
of motor
vehicles and vehicles
and
motorcycles motorcycles
The
statistical Industrial Average results are calculated against companies within
the database for the specific country.
Elements Taken Result
for specific RANKING Total Companies Used
company
DATE OF REGISTRATION 01/09/1992 1 4
TOTAL EMPLOYEES 96 1 4
SALES
(2008) 1 4
SALES
(2007) 1 3
NET
PROFIT (2008) 1 4
NET
PROFIT (2007) 1 3
TOTAL
ASSETS (2008) 1 3
TOTAL
ASSETS (2007) 1 3
Currency: EUROS
Rankings:
The
results given below are calculated against companies with the Database for the
specific country.
Scale: 1
is the highest result found in our database.
Example:
Ranking 5: Total Companies used to generate the Ranking : 20
This means
that this company is the 5th largest company out of 20 found in our database in
the specific industry
Charts of Financial Trends and Industry
Comparisons
PLEASE NOTE THAT CHARTS ARE SHOWN IN EUROS FOR TREND
AND COMPARISON PURPOSES
The
statistical Industrial Average results are calculated against companies within
the database for the specific country.

Subject's
payments reported to be: NO
COMPLAINTS
Name/Title: Mr.
Oghbeta Ould Dellahi Financial Manager
Comment: Subject
has confirmed the general details shown in the report.
Local Reputation: The
company being investigated is considered by local reporters to be
a
Fair / Normal Trade Risk.
General Conclusion: Local
informants consider granting of credit to be a fair trade risk.
Owner/Shareholders Comments: Some of the owners / shareholders have an active
participation in the
running
of the business.
Financial Results Trend: Financial Information indicates that the
business activities of the
company
are declining in strength.
Age of Business: The
company is long established in the local market.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.56.92 |
|
UK Pound |
1 |
Rs.88.91 |
|
Euro |
1 |
Rs.71.25 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.